Cargando…

Critical evaluation of the validity of drug promotion materials in Ethiopia

PURPOSE: This study was conducted to evaluate the validity of drug promotion materials (DPMs) in Ethiopia. METHODS: A cross sectional document review was done. DPMs were evaluated for fulfilment of the World Health Organization’s (WHO) criteria for ethical promotion of drugs. They were also evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hailu, Haftom Gebregergs, Gobezie, Mengistie Yirsaw, Yesuf, Teshager Aklilu, Workneh, Birhanu Demeke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664250/
https://www.ncbi.nlm.nih.gov/pubmed/31440103
http://dx.doi.org/10.2147/DHPS.S200487
_version_ 1783439861065187328
author Hailu, Haftom Gebregergs
Gobezie, Mengistie Yirsaw
Yesuf, Teshager Aklilu
Workneh, Birhanu Demeke
author_facet Hailu, Haftom Gebregergs
Gobezie, Mengistie Yirsaw
Yesuf, Teshager Aklilu
Workneh, Birhanu Demeke
author_sort Hailu, Haftom Gebregergs
collection PubMed
description PURPOSE: This study was conducted to evaluate the validity of drug promotion materials (DPMs) in Ethiopia. METHODS: A cross sectional document review was done. DPMs were evaluated for fulfilment of the World Health Organization’s (WHO) criteria for ethical promotion of drugs. They were also evaluated for font size, type of formulation, claims made, pictures depicted, retrievability and source of references used. RESULTS: A total of 235 DPMs were collected from the community and hospital pharmacies. Documents promoting devices and equipment, orthopedic appliances, reminder cards and drug lists were excluded, leaving 173 promotional materials. Antimicrobials were the most promoted drugs (27.2%) followed by respiratory drugs (11.0%) and gastrointestinal drugs (9.8%). Brand name was written in all of the DPMs while approved generic names, indication and active ingredient per dosage form were written in 94.8%, 92.5% and 62.4% respectively. Side effects and contraindications were written in 27.2% and 18.5% of the DPMs. A total of 223 claims were made. Efficacy was the dominant claim (62.3%) followed by safety (8.5%). Pictorial demonstrations were used in 84.4% of the DPMs. Almost half of the pictures depicted, 47.3%, were the cover of the drug products. Only 48.6% of the DPMs has supported their claims with references. Review articles account for 23.3% of the references. Only 5.8% of the journal articles were published after the year 2013. CONCLUSION: We conclude that the design and content of studied drug promotional materials are most effective as sales materials rather than thorough informational vehicles. The WHO and Food, Medicine and Health Care Administration and Control Authority of Ethiopia recommendations are rarely met.
format Online
Article
Text
id pubmed-6664250
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66642502019-08-22 Critical evaluation of the validity of drug promotion materials in Ethiopia Hailu, Haftom Gebregergs Gobezie, Mengistie Yirsaw Yesuf, Teshager Aklilu Workneh, Birhanu Demeke Drug Healthc Patient Saf Original Research PURPOSE: This study was conducted to evaluate the validity of drug promotion materials (DPMs) in Ethiopia. METHODS: A cross sectional document review was done. DPMs were evaluated for fulfilment of the World Health Organization’s (WHO) criteria for ethical promotion of drugs. They were also evaluated for font size, type of formulation, claims made, pictures depicted, retrievability and source of references used. RESULTS: A total of 235 DPMs were collected from the community and hospital pharmacies. Documents promoting devices and equipment, orthopedic appliances, reminder cards and drug lists were excluded, leaving 173 promotional materials. Antimicrobials were the most promoted drugs (27.2%) followed by respiratory drugs (11.0%) and gastrointestinal drugs (9.8%). Brand name was written in all of the DPMs while approved generic names, indication and active ingredient per dosage form were written in 94.8%, 92.5% and 62.4% respectively. Side effects and contraindications were written in 27.2% and 18.5% of the DPMs. A total of 223 claims were made. Efficacy was the dominant claim (62.3%) followed by safety (8.5%). Pictorial demonstrations were used in 84.4% of the DPMs. Almost half of the pictures depicted, 47.3%, were the cover of the drug products. Only 48.6% of the DPMs has supported their claims with references. Review articles account for 23.3% of the references. Only 5.8% of the journal articles were published after the year 2013. CONCLUSION: We conclude that the design and content of studied drug promotional materials are most effective as sales materials rather than thorough informational vehicles. The WHO and Food, Medicine and Health Care Administration and Control Authority of Ethiopia recommendations are rarely met. Dove 2019-07-24 /pmc/articles/PMC6664250/ /pubmed/31440103 http://dx.doi.org/10.2147/DHPS.S200487 Text en © 2019 Hailu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hailu, Haftom Gebregergs
Gobezie, Mengistie Yirsaw
Yesuf, Teshager Aklilu
Workneh, Birhanu Demeke
Critical evaluation of the validity of drug promotion materials in Ethiopia
title Critical evaluation of the validity of drug promotion materials in Ethiopia
title_full Critical evaluation of the validity of drug promotion materials in Ethiopia
title_fullStr Critical evaluation of the validity of drug promotion materials in Ethiopia
title_full_unstemmed Critical evaluation of the validity of drug promotion materials in Ethiopia
title_short Critical evaluation of the validity of drug promotion materials in Ethiopia
title_sort critical evaluation of the validity of drug promotion materials in ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664250/
https://www.ncbi.nlm.nih.gov/pubmed/31440103
http://dx.doi.org/10.2147/DHPS.S200487
work_keys_str_mv AT hailuhaftomgebregergs criticalevaluationofthevalidityofdrugpromotionmaterialsinethiopia
AT gobeziemengistieyirsaw criticalevaluationofthevalidityofdrugpromotionmaterialsinethiopia
AT yesufteshageraklilu criticalevaluationofthevalidityofdrugpromotionmaterialsinethiopia
AT worknehbirhanudemeke criticalevaluationofthevalidityofdrugpromotionmaterialsinethiopia